Investor: Andrew Spokes
Number of Assets: 151
Reporting Period: Q4 - 2025
Holdings at Report: $20,722,385,989
Return Since Report: -$1,668,092,622
Return Since Report: -8.05%
Company | Position | Activity | Shares | Port. % | Rep. Price | Curr. Price | Rep. Value | Curr. Value | Return Value | Return % |
|---|---|---|---|---|---|---|---|---|---|---|
| Abivax Société Anonyme (ABVX) | Equity | -51.93% | 387,000 | 0.30% | $134.86 | N/A | $52,188,885 | N/A | N/A | N/A |
| Adaptive Biotechnologies Corp. (ADPT) | Equity | +100% | 11,000 | 0.00% | $16.24 | $13.72 | $178,640 | $150,920 | -$27,720 | -15.52% |
| Agios Pharmaceuticals Inc. (AGIO) | Equity | -10.75% | 5,159,505 | 0.81% | $27.22 | $33.83 | $140,441,726 | $174,546,054 | +$34,104,328 | +24.28% |
| Aleanna Inc. | Warrant | +100% | 990,000 | N/A | $0.17 | N/A | $163,499 | N/A | N/A | N/A |
| Aleanna Inc. (ANNA) | Equity | 0% | 78,400 | 0.00% | $2.85 | $8.29 | $223,440 | $649,936 | +$426,496 | +190.88% |
| Alkermes PLC (ALKS) | Equity | 0% | 20,800 | 0.00% | $27.98 | $35.39 | $581,984 | $736,112 | +$154,128 | +26.48% |
| Alnylam Pharmaceuticals Inc. (ALNY) | Put | +100% | 100,000 | N/A | $397.65 | N/A | $39,765,000 | N/A | N/A | N/A |
| Alphabet Inc. (GOOG) | Equity | -29.79% | 787,040 | 1.43% | $313.80 | $286.39 | $246,973,152 | $225,400,386 | -$21,572,766 | -8.73% |
| Altimmune Inc. (ALT) | Equity | 0% | 27,600 | 0.00% | $3.61 | $3.08 | $99,636 | $85,008 | -$14,628 | -14.68% |
| Alvotech (ALVO) | Equity | 0% | 199,675 | 0.01% | $5.13 | $3.43 | $1,024,333 | $684,885 | -$339,448 | -33.14% |
| Amazon.com Inc. (AMZN) | Equity | +28.36% | 4,499,894 | 6.00% | $230.82 | $208.30 | $1,038,665,533 | $937,327,920 | -$101,337,613 | -9.76% |
| Amicus Therapeutics Inc. (FOLD) | Equity | 0% | 16,000 | 0.00% | $14.24 | $14.46 | $227,840 | $231,360 | +$3,520 | +1.54% |
| Amkor Technology Inc. (AMKR) | Equity | +100% | 464,000 | 0.11% | $39.48 | N/A | $18,318,720 | N/A | N/A | N/A |
| Aon PLC (AON) | Equity | +17.00% | 2,665,238 | 5.43% | $352.88 | $322.58 | $940,509,185 | $859,752,474 | -$80,756,711 | -8.59% |
| Aramark (ARMK) | Equity | +4.01% | 9,357,046 | 1.99% | $36.86 | $40.52 | $344,900,716 | $379,100,719 | +$34,200,003 | +9.92% |
| Arcellx Inc. (ACLX) | Equity | 0% | 4,000 | 0.00% | $65.20 | $114.82 | $260,800 | $459,264 | +$198,464 | +76.10% |
| Arcutis Biotherapeutics Inc. (ARQT) | Equity | 0% | 26,000 | 0.00% | $29.04 | $23.56 | $755,040 | $612,560 | -$142,480 | -18.87% |
| Ardelyx Inc. (ARDX) | Equity | 0% | 23,000 | 0.00% | $5.83 | $5.99 | $134,090 | $137,655 | +$3,565 | +2.66% |
| Arrowhead Pharmaceuticals Inc. (ARWR) | Equity | 0% | 15,800 | 0.01% | $66.39 | $62.70 | $1,048,962 | $990,660 | -$58,302 | -5.56% |
| Ascendis Pharma A/S (ASND) | Equity | 0% | 1,400 | 0.00% | $213.24 | $228.73 | $298,536 | $320,222 | +$21,686 | +7.26% |
| Assembly Biosciences Inc. (ASMB) | Equity | 0% | 1,227,590 | 0.24% | $34.01 | N/A | $41,750,336 | N/A | N/A | N/A |
| Axsome Therapeutics Inc. (AXSM) | Equity | 0% | 4,000 | 0.00% | $182.64 | $169.02 | $730,560 | $676,080 | -$54,480 | -7.46% |
| Baidu Inc. (BIDU) | Equity | +51.59% | 315,300 | 0.24% | $130.66 | $111.68 | $41,197,098 | $35,212,704 | -$5,984,394 | -14.53% |
| Beam Therapeutics Inc. (BEAM) | Equity | 0% | 10,063,111 | 1.61% | $27.72 | $23.83 | $278,949,437 | $239,803,935 | -$39,145,502 | -14.03% |
| Beigene Ltd (ONC) | Equity | 0% | 1,100 | 0.00% | $303.81 | $316.90 | $334,191 | $348,590 | +$14,399 | +4.31% |
| Beta Bionics Inc. (BBNX) | Equity | 0% | 4,313,920 | 0.76% | $30.47 | $10.02 | $131,445,142 | $43,225,478 | -$88,219,664 | -67.12% |
| Beyond Meat Inc. (BYND) | Equity | +100% | 19,000 | 0.00% | $0.82 | $0.70 | $15,580 | $13,338 | -$2,242 | -14.39% |
| Biocryst Pharmaceuticals Inc. (BCRX) | Equity | 0% | 24,000 | 0.00% | $7.80 | $9.52 | $187,200 | $228,480 | +$41,280 | +22.05% |
| Bitwise 10 Crypto Index ETF | Equity | +100% | 3,385,500 | 1.15% | $58.76 | N/A | $198,931,980 | N/A | N/A | N/A |
| Blue Gold LTD | Warrant | +100% | 300,000 | N/A | $0.44 | N/A | $132,000 | N/A | N/A | N/A |
| Boston Scientific Corp. (BSX) | Equity | +56.74% | 7,439,564 | 4.09% | $95.35 | $62.36 | $709,362,427 | $463,894,013 | -$245,468,414 | -34.60% |
| Bridgebio Pharma Inc. (BBIO) | Equity | +9.84% | 8,998,463 | 3.97% | $76.49 | $74.60 | $688,292,435 | $671,285,340 | -$17,007,095 | -2.47% |
| Brightspring Health Services Inc. (BTSG) | Equity | 0% | 22,000 | 0.00% | $37.45 | $42.59 | $823,900 | $936,980 | +$113,080 | +13.72% |
| Broadcom Inc. (AVGO) | Equity | +100% | 892,400 | 1.78% | $346.10 | $309.45 | $308,859,640 | $276,148,718 | -$32,710,922 | -10.59% |
| C4 Therapeutics Inc. (CCCC) | Equity | 0% | 28,000 | 0.00% | $1.91 | $2.63 | $53,480 | $73,640 | +$20,160 | +37.70% |
| Canopy Growth Corp. (CGC) | Equity | 0% | 30,000 | 0.00% | $1.14 | $0.95 | $34,200 | $28,470 | -$5,730 | -16.75% |
| Capricor Therapeutics Inc. (CAPR) | Equity | 0% | 41,000 | 0.01% | $28.86 | $30.40 | $1,183,260 | $1,246,400 | +$63,140 | +5.34% |
| Cardinal Health Inc. (CAH) | Equity | +127.67% | 576,000 | 0.68% | $205.50 | $211.33 | $118,368,000 | $121,723,200 | +$3,355,200 | +2.83% |
| CBRE Group Inc. (CBRE) | Equity | -39.12% | 983,771 | 0.91% | $160.79 | $135.45 | $158,180,539 | $133,251,782 | -$24,928,757 | -15.76% |
| Celcuity Inc. (CELC) | Equity | +100% | 4,000 | 0.00% | $99.74 | N/A | $398,960 | N/A | N/A | N/A |
| Cencora Inc. (COR) | Equity | 0% | 1,000 | 0.00% | $337.75 | $313.57 | $337,750 | $313,570 | -$24,180 | -7.16% |
| Centessa Pharmaceuticals PLC (CNTA) | Equity | +24.14% | 5,377,068 | 0.78% | $25.01 | $39.72 | $134,480,471 | $213,577,141 | +$79,096,670 | +58.82% |
| CG Oncology Inc. (CGON) | Equity | 0% | 8,000 | 0.00% | $41.52 | $67.68 | $332,160 | $541,440 | +$209,280 | +63.01% |
| Cidara Therapeutics Inc. (CDTX) | Equity | -24.65% | 382,800 | 0.49% | $220.89 | $221.38 | $84,556,692 | $84,744,264 | +$187,572 | +0.22% |
| Cogent Biosciences Inc. (COGT) | Equity | 0% | 17,000 | 0.00% | $35.52 | $38.50 | $603,840 | $654,500 | +$50,660 | +8.39% |
| Crinetics Pharmaceuticals Inc. (CRNX) | Equity | +20.16% | 6,933,098 | 1.86% | $46.55 | $36.32 | $322,735,712 | $251,810,119 | -$70,925,593 | -21.98% |
| Cyberark Software Ltd. (CYBR) | Equity | +100% | 1,053,040 | 2.71% | $446.06 | $408.85 | $469,719,022 | $430,535,404 | -$39,183,618 | -8.34% |
| Dayforce Inc. (DAY) | Equity | +100% | 2,925,000 | 1.17% | $69.16 | $69.86 | $202,293,000 | $204,340,500 | +$2,047,500 | +1.01% |
| The Walt Disney Company (DIS) | Equity | -20.64% | 4,125,991 | 2.71% | $113.77 | $96.32 | $469,413,996 | $397,415,453 | -$71,998,543 | -15.34% |
| Doximity Inc. (DOCS) | Equity | -16.84% | 311,000 | 0.08% | $44.28 | $23.29 | $13,771,080 | $7,243,190 | -$6,527,890 | -47.40% |
| Dyne Therapeutics Inc. (DYN) | Equity | 0% | 10,000 | 0.00% | $19.56 | $18.13 | $195,600 | $181,300 | -$14,300 | -7.31% |
| Eli Lilly and Company (LLY) | Put | +100% | 375,000 | N/A | $1,074.68 | N/A | $403,005,000 | N/A | N/A | N/A |
| Enanta Pharmaceuticals Inc. (ENTA) | Equity | +30.63% | 2,772,262 | 0.25% | $15.77 | $12.63 | $43,718,572 | $35,013,669 | -$8,704,903 | -19.91% |
| Encompass Health Corp. (EHC) | Equity | -58.93% | 234,500 | 0.14% | $106.14 | $96.41 | $24,889,830 | $22,608,145 | -$2,281,685 | -9.17% |
| Establishment Labs Holdings Inc. (ESTA) | Equity | +100% | 3,000 | 0.00% | $72.88 | $56.78 | $218,640 | $170,340 | -$48,300 | -22.09% |
| Evolent Health Inc. (EVH) | Equity | 0% | 14,000 | 0.00% | $4.00 | $2.29 | $56,000 | $31,990 | -$24,010 | -42.88% |
| Exelixis Inc. (EXEL) | Equity | -19.44% | 15,709,500 | 3.97% | $43.83 | $42.89 | $688,547,385 | $673,780,455 | -$14,766,930 | -2.14% |
| GE Healthcare Technologies Inc. (GEHC) | Equity | 0% | 3,000 | 0.00% | $82.02 | $71.09 | $246,060 | $213,270 | -$32,790 | -13.33% |
| Genedx Holdings Corp. (WGS) | Equity | +1300.00% | 70,000 | 0.05% | $130.06 | $64.22 | $9,104,200 | $4,495,400 | -$4,608,800 | -50.62% |
| Geron Corp. (GERN) | Equity | 0% | 43,000 | 0.00% | $1.32 | $1.49 | $56,760 | $64,070 | +$7,310 | +12.88% |
| Glaukos Corp. (GKOS) | Equity | 0% | 2,600 | 0.00% | $112.91 | $107.69 | $293,566 | $279,994 | -$13,572 | -4.62% |
| Globus Medical Inc. (GMED) | Equity | 0% | 4,000 | 0.00% | $87.31 | $86.15 | $349,240 | $344,600 | -$4,640 | -1.33% |
| Grail Inc. (GRAL) | Equity | +73.66% | 2,342,684 | 1.16% | $85.59 | $51.68 | $200,510,323 | $121,069,909 | -$79,440,414 | -39.62% |
| Grayscale Ethereum Mini Trust ETF (ETH) | Equity | +100% | 228,340 | 0.04% | $28.06 | N/A | $6,407,220 | N/A | N/A | N/A |
| Grifols S.A. (GRFS) | Equity | 0% | 28,000 | 0.00% | $9.35 | $8.02 | $261,800 | $224,560 | -$37,240 | -14.22% |
| Guardant Health Inc. (GH) | Equity | +1262.50% | 109,000 | 0.06% | $102.14 | $92.37 | $11,133,260 | $10,068,330 | -$1,064,930 | -9.57% |
| Healthcare Realty Trust Inc. (HR) | Equity | 0% | 12,000 | 0.00% | $16.95 | $16.95 | $203,400 | $203,340 | -$60 | -0.03% |
| Healthequity Inc. (HQY) | Equity | 0% | 5,000 | 0.00% | $91.61 | $83.57 | $458,050 | $417,850 | -$40,200 | -8.78% |
| Hims & Hers Health Inc. (HIMS) | Equity | -68.48% | 3,386,986 | 0.63% | $32.47 | $20.77 | $109,975,435 | $70,347,699 | -$39,627,736 | -36.03% |
| Icon Public Limited Company (ICLR) | Equity | 0% | 1,200 | 0.00% | $182.22 | $110.66 | $218,664 | $132,792 | -$85,872 | -39.27% |
| Immunovant Inc. (IMVT) | Equity | 0% | 12,000 | 0.00% | $25.42 | $24.84 | $305,040 | $298,080 | -$6,960 | -2.28% |
| Insmed Inc. (INSM) | Equity | 0% | 3,000 | 0.00% | $174.04 | $163.52 | $522,120 | $490,560 | -$31,560 | -6.04% |
| Insmed Incorporated (INSM) | Call | +100% | 250,000 | N/A | $174.04 | N/A | $43,510,000 | N/A | N/A | N/A |
| Invesco S&P 500 Equal Weight ETF (RSP) | Put | +100% | 3,600,000 | N/A | $191.56 | N/A | $689,616,000 | N/A | N/A | N/A |
| Ionis Pharmaceuticals Inc. (IONS) | Equity | 0% | 4,800 | 0.00% | $79.11 | N/A | $379,728 | N/A | N/A | N/A |
| Iovance Biotherapeutics Inc. (IOVA) | Equity | 0% | 26,000 | 0.00% | $2.73 | $3.51 | $70,980 | $91,260 | +$20,280 | +28.57% |
| Ironwood Pharmaceuticals Inc. (IRWD) | Equity | 0% | 13,000 | 0.00% | $3.37 | $1.54 | $43,810 | $19,955 | -$23,855 | -54.45% |
| Ishares Bitcoin Trust ETF (IBIT) | Equity | -69.44% | 2,137,100 | 0.61% | $49.65 | $38.39 | $106,107,015 | $82,032,584 | -$24,074,432 | -22.69% |
| Ishares Ethereum TR | Equity | -80.12% | 1,481,001 | 0.19% | $22.43 | N/A | $33,218,852 | N/A | N/A | N/A |
| Ishares Iboxx $ High Yield Corporate Bond ETF (HYG) | Put | +100% | 8,000,000 | N/A | $80.63 | N/A | $645,040,000 | N/A | N/A | N/A |
| Joyy Inc. (YY) | Equity | -7.49% | 578,200 | 0.22% | $64.76 | $56.47 | $37,444,232 | $32,650,954 | -$4,793,278 | -12.80% |
| KKR & Co. Inc. (KKR) | Equity | +100% | 2,017,700 | 1.48% | $127.48 | $93.01 | $257,216,396 | $187,666,277 | -$69,550,119 | -27.04% |
| Krystal Biotech Inc. (KRYS) | Equity | 0% | 2,000 | 0.00% | $246.54 | $258.32 | $493,080 | $516,640 | +$23,560 | +4.78% |
| Lantheus Holdings Inc. (LNTH) | Equity | +56.09% | 5,427,479 | 2.08% | $66.55 | $75.85 | $361,198,727 | $411,674,282 | +$50,475,555 | +13.97% |
| Liquidia Corp. (LQDA) | Equity | +1.06% | 8,656,038 | 1.72% | $34.49 | $37.74 | $298,546,751 | $326,678,874 | +$28,132,123 | +9.42% |
| Livanova PLC (LIVN) | Equity | 0% | 6,000 | 0.00% | $61.53 | $63.56 | $369,180 | $381,360 | +$12,180 | +3.30% |
| Madrigal Pharmaceuticals Inc. (MDGL) | Equity | 0% | 3,319 | 0.01% | $582.34 | $523.47 | $1,932,786 | $1,737,397 | -$195,389 | -10.11% |
| Mastercard Inc. (MA) | Equity | -19.23% | 172,671 | 0.57% | $570.88 | $499.72 | $98,574,420 | $86,287,152 | -$12,287,268 | -12.46% |
| Mckesson Corp. (MCK) | Equity | -8.62% | 298,900 | 1.42% | $820.29 | $864.18 | $245,184,681 | $258,303,402 | +$13,118,721 | +5.35% |
| Medline INC | Equity | +100% | 260,000 | 0.06% | $42.00 | N/A | $10,920,000 | N/A | N/A | N/A |
| Merit Medical Systems Inc. (MMSI) | Equity | 0% | 3,000 | 0.00% | $88.14 | $68.93 | $264,420 | $206,790 | -$57,630 | -21.79% |
| Microsoft Corp. (MSFT) | Equity | +15.73% | 2,214,079 | 6.18% | $483.62 | $370.17 | $1,070,772,886 | $819,585,623 | -$251,187,263 | -23.46% |
| Mineralys Therapeutics Inc. (MLYS) | Equity | -50.79% | 823,296 | 0.17% | $36.29 | N/A | $29,877,412 | N/A | N/A | N/A |
| Minerva Neurosciences Inc. (NERV) | Equity | +100% | 2,365,000 | 0.05% | $4.02 | N/A | $9,507,300 | N/A | N/A | N/A |
| Mirum Pharmaceuticals Inc. (MIRM) | Equity | 0% | 3,000 | 0.00% | $78.99 | $92.38 | $236,970 | $277,140 | +$40,170 | +16.95% |
| Nasdaq Inc. (NDAQ) | Equity | -17.49% | 2,989,213 | 1.68% | $97.13 | $84.89 | $290,342,259 | $253,754,292 | -$36,587,967 | -12.60% |
| Natera Inc. (NTRA) | Equity | -7.97% | 3,914,366 | 5.18% | $229.09 | $199.53 | $896,742,107 | $781,033,448 | -$115,708,659 | -12.90% |
| Neogenomics Inc. (NEO) | Equity | +100% | 19,000 | 0.00% | $11.76 | N/A | $223,440 | N/A | N/A | N/A |
| New Oriental Education & Technology Group Inc. (EDU) | Equity | -65.32% | 196,000 | 0.06% | $55.03 | $56.67 | $10,785,880 | $11,107,320 | +$321,440 | +2.98% |
| The New York Times Company (NYT) | Equity | -34.20% | 3,280,678 | 1.31% | $69.42 | $83.73 | $227,744,667 | $274,691,169 | +$46,946,502 | +20.61% |
| Novavax Inc. (NVAX) | Equity | -75.00% | 195,000 | 0.01% | $6.72 | $8.14 | $1,310,400 | $1,587,300 | +$276,900 | +21.13% |
| Nuvalent Inc. (NUVL) | Equity | 0% | 3,000 | 0.00% | $100.59 | $102.45 | $301,770 | $307,350 | +$5,580 | +1.85% |
| Nuvation Bio Inc. (NUVB) | Equity | +100% | 29,000 | 0.00% | $8.96 | $4.28 | $259,840 | $123,975 | -$135,865 | -52.29% |
| NVNI Group Limited | Warrant | +100% | 375,000 | N/A | $0.06 | N/A | $22,500 | N/A | N/A | N/A |
| Ocular Therapeutix Inc. (OCUL) | Equity | +100% | 18,000 | 0.00% | $12.14 | N/A | $218,520 | N/A | N/A | N/A |
| Omeros Corporation (OMER) | Equity | +100% | 23,000 | 0.00% | $17.18 | N/A | $395,025 | N/A | N/A | N/A |
| Oscar Health Inc. (OSCR) | Equity | -92.75% | 264,000 | 0.02% | $14.37 | $11.49 | $3,793,680 | $3,032,040 | -$761,640 | -20.08% |
| Pacific Biosciences Of California Inc. (PACB) | Equity | 0% | 135,000 | 0.00% | $1.87 | $1.32 | $252,450 | $178,200 | -$74,250 | -29.41% |
| Perceptive Capital Solutions corp (PCSC) | Equity | +100% | 2,250,000 | 0.17% | $13.03 | N/A | $29,317,500 | N/A | N/A | N/A |
| Precigen Inc. (PGEN) | Equity | +100% | 50,000 | 0.00% | $4.18 | $3.80 | $209,000 | $190,000 | -$19,000 | -9.09% |
| Prime Medicine Inc. (PRME) | Equity | -73.88% | 1,240,843 | 0.02% | $3.47 | $3.48 | $4,305,725 | $4,318,134 | +$12,409 | +0.29% |
| Progyny Inc. (PGNY) | Equity | 0% | 18,000 | 0.00% | $25.68 | $17.01 | $462,240 | $306,180 | -$156,060 | -33.76% |
| Protagonist Therapeutics Inc. (PTGX) | Equity | -0.84% | 6,144,006 | 3.10% | $87.34 | $105.40 | $536,617,484 | $647,578,232 | +$110,960,748 | +20.68% |
| Rani Therapeutics Holdings Inc. (RANI) | Equity | +100% | 78,000 | 0.00% | $1.35 | N/A | $105,300 | N/A | N/A | N/A |
| Revolution Medicines Inc. (RVMD) | Equity | -0.29% | 14,582,796 | 6.70% | $79.65 | $49.16 | $1,161,519,701 | $716,890,251 | -$444,629,450 | -38.28% |
| Revolution Medicines Inc. (RVMDW) | Warrant | +100% | 120,085 | N/A | $0.94 | N/A | $112,868 | N/A | N/A | N/A |
| Roivant Sciences Ltd. (ROIV) | Equity | 0% | 37,000 | 0.00% | $21.70 | $27.67 | $802,900 | $1,023,790 | +$220,890 | +27.51% |
| Sabra Health Care Reit Inc. (SBRA) | Equity | 0% | 14,000 | 0.00% | $18.94 | $19.23 | $265,160 | $269,220 | +$4,060 | +1.53% |
| Salesforce Inc. (CRM) | Equity | -48.78% | 1,261,177 | 1.93% | $264.91 | $186.39 | $334,098,399 | $235,072,042 | -$99,026,357 | -29.64% |
| Scholar Rock Holding Corp. (SRRK) | Equity | 0% | 7,000 | 0.00% | $44.05 | $49.16 | $308,350 | $344,120 | +$35,770 | +11.60% |
| Schrödinger Inc. (SDGR) | Equity | -75.00% | 71,000 | 0.01% | $17.88 | $11.36 | $1,269,480 | $806,560 | -$462,920 | -36.47% |
| The Charles Schwab Corp. (SCHW) | Equity | +2.71% | 3,339,657 | 1.93% | $99.91 | $93.86 | $333,665,131 | $313,460,206 | -$20,204,925 | -6.06% |
| Soleno Therapeutics Inc. (SLNO) | Equity | -96.73% | 5,000 | 0.00% | $46.30 | $33.48 | $231,500 | $167,400 | -$64,100 | -27.69% |
| Solid Power Inc. (SLDPW) | Warrant | +100% | 405,316 | N/A | $0.71 | N/A | $286,883 | N/A | N/A | N/A |
| SPDR S&P 500 ETF Trust (SPY) | Put | +100% | 3,000,000 | N/A | $681.92 | N/A | $2,045,760,000 | N/A | N/A | N/A |
| Stoke Therapeutics Inc. (STOK) | Equity | +100% | 9,000 | 0.00% | $31.74 | N/A | $285,660 | N/A | N/A | N/A |
| Structure Therapeutics Inc. (GPCR) | Equity | +100% | 454,000 | 0.18% | $69.55 | N/A | $31,575,700 | N/A | N/A | N/A |
| Summit Midstream Corp. (SMC) | Equity | 0% | 58,214 | 0.01% | $26.68 | $30.23 | $1,553,150 | $1,759,809 | +$206,659 | +13.31% |
| Sunococorp LLC | Equity | +100% | 606,277 | 0.17% | $49.28 | N/A | $29,877,331 | N/A | N/A | N/A |
| Syndax Pharmaceuticals Inc. (SNDX) | Equity | 0% | 10,000 | 0.00% | $21.01 | $23.36 | $210,100 | $233,600 | +$23,500 | +11.19% |
| Synopsys Inc. (SNPS) | Equity | +100% | 999,200 | 2.71% | $469.72 | $396.88 | $469,344,224 | $396,562,496 | -$72,781,728 | -15.51% |
| Tango Therapeutics Inc. (TNGX) | Equity | +21.42% | 13,061,411 | 0.67% | $8.86 | $20.93 | $115,724,101 | $273,375,332 | +$157,651,231 | +136.23% |
| Tenet Healthcare Corp. (THC) | Equity | -10.11% | 372,153 | 0.43% | $198.72 | $188.67 | $73,954,244 | $70,214,107 | -$3,740,137 | -5.06% |
| Terns Pharmaceuticals Inc. (TERN) | Equity | +100% | 642,000 | 0.15% | $40.40 | N/A | $25,936,800 | N/A | N/A | N/A |
| Teva Pharmaceutical Industries Limited (TEVA) | Equity | -99.20% | 40,000 | 0.01% | $31.21 | $30.01 | $1,248,400 | $1,200,400 | -$48,000 | -3.84% |
| Thermo Fisher Scientific Inc. (TMO) | Equity | -49.48% | 635,685 | 2.13% | $579.45 | $492.01 | $368,347,673 | $312,760,198 | -$55,587,475 | -15.09% |
| Transunion (TRU) | Equity | -85.74% | 675,000 | 0.33% | $85.75 | $69.19 | $57,881,250 | $46,703,250 | -$11,178,000 | -19.31% |
| Travere Therapeutics Inc. (TVTX) | Equity | 0% | 12,000 | 0.00% | $38.21 | $29.69 | $458,520 | $356,280 | -$102,240 | -22.30% |
| Tvardi Therapeutics INC | Equity | 0% | 43,225 | 0.00% | $4.30 | $0.00 | $185,868 | $0 | -$185,868 | -100% |
| Twist Bioscience Corp. (TWST) | Equity | 0% | 7,650 | 0.00% | $31.72 | $47.52 | $242,658 | $363,528 | +$120,870 | +49.81% |
| Tyra Biosciences Inc. (TYRA) | Equity | +80.69% | 2,066,818 | 0.31% | $26.29 | $38.30 | $54,336,645 | $79,159,129 | +$24,822,484 | +45.68% |
| Uniqure N.V. (QURE) | Equity | -97.52% | 14,000 | 0.00% | $23.93 | $16.35 | $335,020 | $228,900 | -$106,120 | -31.68% |
| UnitedHealth Group Inc. (UNH) | Equity | -15.24% | 1,598,906 | 3.05% | $330.11 | $270.78 | $527,814,860 | $432,951,767 | -$94,863,093 | -17.97% |
| Urogen Pharma Ltd. (URGN) | Equity | 0% | 11,000 | 0.00% | $23.42 | N/A | $257,620 | N/A | N/A | N/A |
| Vaxcyte Inc. (PCVX) | Equity | +100% | 5,000 | 0.00% | $46.14 | $57.91 | $230,700 | $289,525 | +$58,825 | +25.50% |
| Veracyte Inc. (VCYT) | Equity | 0% | 7,000 | 0.00% | $42.10 | N/A | $294,700 | N/A | N/A | N/A |
| Verastem Inc. (VSTM) | Equity | +100% | 2,000,000 | 0.09% | $7.72 | N/A | $15,440,000 | N/A | N/A | N/A |
| Visa Inc. (V) | Equity | +16.02% | 695,910 | 1.41% | $350.71 | $301.42 | $244,062,596 | $209,757,713 | -$34,304,883 | -14.06% |
| VNet Group Inc. (VNET) | Equity | +14.51% | 6,285,386 | 0.31% | $8.46 | $8.39 | $53,174,366 | $52,734,389 | -$439,977 | -0.83% |
| Westinghouse Air Brake Technologies Corp. (WAB) | Equity | +12.29% | 2,476,003 | 3.05% | $213.45 | $250.02 | $528,502,840 | $619,050,270 | +$90,547,430 | +17.13% |
| Welltower Inc. (WELL) | Equity | +100% | 343,000 | 0.37% | $185.61 | $197.74 | $63,664,230 | $67,824,820 | +$4,160,590 | +6.54% |